SCHEMBL7992187

SCHEMBL7992187

Cc1cccc(Cn2cnc3[nH]c(CCN)nc(=O)c32)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
HPGD P15428 7/20 0.42
TSHR P16473 5/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
CNOT7 Q9UIV1 2/20 0.40
PARN O95453 1/20 0.40
ALOX15 P16050 1/20 0.39
MMP13 P45452 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
RECQL P46063 1/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988665 0.90 ALDH1A1 (0.44) ALDH1A1CYP11B1CYP11B2HPGDTSHR
SCHEMBL7974262 0.88 ALDH1A1 (0.45) ALDH1A1CYP11B1CYP11B2HPGDTSHR
SCHEMBL7988534 0.87 TAAR1 (0.41) TAAR1CNOT7PARNIDO1
SCHEMBL7988676 0.87 SMN1; SMN2 (0.47) HTTSMN1; SMN2TAAR1CNOT7PARN
SCHEMBL7975139 0.87 CNOT7 (0.40) CYP11B1CYP11B2HPGDTSHRLMNA
SCHEMBL7985278 0.87 TP53 (0.50) LMNATAAR1MAPTTP53
SCHEMBL7985640 0.87 CNOT7 (0.53) ALDH1A1HPGDSMN1; SMN2CNOT7PARN
SCHEMBL7988359 0.86 ALDH1A1 (0.44) ALDH1A1CYP11B1CYP11B2HPGDTSHR
Hydrochloric Acid SCHEMBL7987619 0.85 CNOT7 (0.52) ALDH1A1HPGDSMN1; SMN2CNOT7PARN
SCHEMBL7992185 0.83 HPGD (0.45) ALDH1A1CYP11B1CYP11B2HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed